Log in
TSE:ACB

Aurora Cannabis Inc. (ACB.TO) Stock Forecast, Price & News

C$5.38
-0.06 (-1.10 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
C$5.17
Now: C$5.38▼
C$5.44
50-Day Range
C$5.08
MA: C$6.92▼
C$9.76
52-Week Range
C$4.93
Now: C$5.38▼
C$61.80
Volume2.05 million shs
Average Volume1.69 million shs
Market CapitalizationC$653.83 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More
Aurora Cannabis Inc. (ACB.TO) logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.1Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.26 out of 5 stars

Industry, Sector and Symbol

Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:ACB
Previous Symbol
CUSIPN/A
CIKN/A
Webauroramj.com
Phone+1-604-3625207
Employees2,731

Debt

Debt-to-Equity Ratio24.98
Current Ratio1.54
Quick Ratio0.82

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesC$278.91 million
Price / Sales2.34
Cash FlowC$1.38 per share
Price / Cash Flow3.91
Book ValueC$18.67 per share
Price / Book0.29

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares121,529,000
Market CapC$653.83 million
Next Earnings Date11/9/2020 (Confirmed)
OptionableNot Optionable
C$5.38
-0.06 (-1.10 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aurora Cannabis Inc. (ACB.TO) (TSE:ACB) Frequently Asked Questions

How has Aurora Cannabis Inc. (ACB.TO)'s stock price been impacted by COVID-19 (Coronavirus)?

Aurora Cannabis Inc. (ACB.TO)'s stock was trading at C$1.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ACB shares have increased by 359.8% and is now trading at C$5.38.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Aurora Cannabis Inc. (ACB.TO)?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis Inc. (ACB.TO) in the last year. There are currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Aurora Cannabis Inc. (ACB.TO).

When is Aurora Cannabis Inc. (ACB.TO)'s next earnings date?

Aurora Cannabis Inc. (ACB.TO) is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for Aurora Cannabis Inc. (ACB.TO).

How were Aurora Cannabis Inc. (ACB.TO)'s earnings last quarter?

Aurora Cannabis Inc. (ACB.TO) (TSE:ACB) posted its quarterly earnings data on Monday, May, 15th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The firm earned $5.18 million during the quarter, compared to analyst estimates of $7.44 million.
View Aurora Cannabis Inc. (ACB.TO)'s earnings history.

What price target have analysts set for ACB?

8 equities research analysts have issued 1 year target prices for Aurora Cannabis Inc. (ACB.TO)'s stock. Their forecasts range from C$3.60 to C$12.00. On average, they anticipate Aurora Cannabis Inc. (ACB.TO)'s share price to reach C$8.90 in the next year. This suggests a possible upside of 65.4% from the stock's current price.
View analysts' price targets for Aurora Cannabis Inc. (ACB.TO).

Who are some of Aurora Cannabis Inc. (ACB.TO)'s key competitors?

Some companies that are related to Aurora Cannabis Inc. (ACB.TO) include Aphria Inc. (APHA.TO) (APHA), Knight Therapeutics Inc. (GUD.TO) (GUD), HLS Therapeutics (HLS), Hexo (HEXO), Amryt Pharma plc (AMYT.L) (AMYT), OrganiGram (OGI), HEXO (HEXO), Benchmark (BMK), ICC Labs Inc. (ICC.V) (ICC), Shield Therapeutics plc (STX.L) (STX), ESSA Pharma Inc. (EPI.V) (EPI), cbdMD (YCBD), The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGOD), WeedMD Inc. (WMD.V) (WMD) and Delta 9 Cannabis (NINE).
View all competitors.

What other stocks do shareholders of Aurora Cannabis Inc. (ACB.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis Inc. (ACB.TO) investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria Inc. (APHA.TO) (APHA), OrganiGram (OGI), Aurora Cannabis (ACBFF), Cronos Group (CRON), Micron Technology (MU), Alibaba Group (BABA), The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGOD) and Advanced Micro Devices (AMD).

Who are Aurora Cannabis Inc. (ACB.TO)'s key executives?

Aurora Cannabis Inc. (ACB.TO)'s management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 55, Pay $537.2k)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.P.A., C.A., ICD.D., Chief Operating Officer
  • Ms. Jillian Swainson, Chief Legal Officer & Corp. Sec.
  • Mr. Miguel Martin, CEO & Director (Age 48)
  • Mr. Darryl Vleeming, Exec. VP of Information Services
  • Dr. Jonathan Page Ph.D., Chief Science Officer (Age 51)
  • Ananth Krishnan, VP of Capital Markets & Investor Relations
  • Michelle Lefler, VP of Communications & PR
  • Mr. Carey Squires, Exec. VP, Corp. Devel. & Strategy

What is Aurora Cannabis Inc. (ACB.TO)'s stock symbol?

Aurora Cannabis Inc. (ACB.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

How do I buy shares of Aurora Cannabis Inc. (ACB.TO)?

Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Aurora Cannabis Inc. (ACB.TO)'s stock price today?

One share of ACB stock can currently be purchased for approximately C$5.38.

How big of a company is Aurora Cannabis Inc. (ACB.TO)?

Aurora Cannabis Inc. (ACB.TO) has a market capitalization of C$653.83 million and generates C$278.91 million in revenue each year. Aurora Cannabis Inc. (ACB.TO) employs 2,731 workers across the globe.

What is Aurora Cannabis Inc. (ACB.TO)'s official website?

The official website for Aurora Cannabis Inc. (ACB.TO) is auroramj.com.

How can I contact Aurora Cannabis Inc. (ACB.TO)?

Aurora Cannabis Inc. (ACB.TO)'s mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.

This page was last updated on 10/31/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.